Susan Hasty, Publisher
Table of Contents . . . September 29th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Angiogenesis Weekly | Other Publications
Colorectal Cancer - Abundance of Growth Factor May Mean Trouble for Ulcerative Colitis Patients
Anti-Angiogenesis - Mouse Models Show Endostatin Inhibits Breast and Prostate Cancer Growth
Breast Cancer - Changes in Matrix Proteins Might be Basis for Loss of Estrogen Responsiveness
Colorectal Cancer - Vascular Endothelial Growth Factor is Prognostic Factor
Diabetes - Impaired Wound Healing Leads to Infections in an Animal Model
Endometriosis - Chemokine Eotaxin May Play Role in Inflammatory Processes
Exercise - Physical Exertion Influences Angiotensin II Induction of Angiogenesis
Prostate Cancer - Synergy Between Vitamin D and Hepatocyte Growth Factor Limits Androgen-Insensitive Disease
Lung Cancer - Phase II Data on Growth Factor Receptor Inhibitor Released
Tissue Regeneration - FDA Approves Marketing of Atrisorb Barrier with Doxycycline
Anti-Coagulation - Heparin Used in Cardiovascular Procedures Induces Activin and Follistatin
Drug Development - Control Over Kinase Activities Could Lead to Control of Signaling Pathways
Liver Cancer - UCLA Launches State-of-the-Art Treatment and Research Center
Melanoma - Anti-Angiogenic Gene Therapy Inhibited Experimental Eyelid Melanoma
Risk Factors - Cigarette Smoke Chokes the Heart
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.